BYAM REBECCA (Chief Financial Officer) received a stock award from HCW BIOLOGICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/22/2024ACC: 0001209191-24-003782
Officer· Chief Financial Officer
Since Jul 2021
+760.71K
Net shares
Net buyer
$1.06M
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
760.71K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+760.71K
Price / share
$1.40
Trade value
$1.06M
% of position
122.5%
2/20/2024
621.20K→1.38M
Total
Net shares
+760.71K
Net value
$1.06M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/20/2024 | A · Award | +760.71K | $1.40 | $1.06M | 122.5% | 621.20K | 1.38M |
| Total | +760.71K | $1.06M | ||||||
Derivative Transactions0
No derivative transactions reported